Literature DB >> 8610485

Fatigue in MS is associated with specific clinical features.

C Colosimo1, E Millefiorini, M G Grasso, F Vinci, M Fiorelli, T Koudriavtseva, C Pozzilli.   

Abstract

INTRODUCTION: fatigue is a common and disabling symptom in multiple sclerosis (MS). In this study we evaluated if fatigue is associated with different demographic and clinical features of MS. MATERIAL: A survey was performed on 507 consecutive patients affected by clinically definite MS referred to our centre between January 1 and December 31, 1993. During the examination patients were asked to answer a brief fatigue questionnaire. To evaluate the probability of the occurrence of fatigue in association with several covariant factors (age, sex, duration, disease form, disease severity, month of examination, functional sub-systems on the expanded disability status scale (EDSS), a logistic regression analysis was performed.
RESULTS: we confirmed that fatigue is common in MS, recorded in 53% of patients. Patients affected by a more severe disability, by progressive MS, both primary and secondary, with an older age at examination, and assessed during spring, had a significantly higher risk of fatigue. Sex was not associated with the occurrence of fatigue. When the single items of EDSS were considered, we found that fatigue is also associated with the occurrence of cerebellar, sphincteric, pyramidal and sensitive signs, but not with brain stem, visual and cognitive impairment.
CONCLUSION: fatigue in MS is more frequent in association with specific clinical features.

Entities:  

Mesh:

Year:  1995        PMID: 8610485     DOI: 10.1111/j.1600-0404.1995.tb00145.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  30 in total

Review 1.  Fatigue in multiple sclerosis: definition, pathophysiology and treatment.

Authors:  Lauren B Krupp
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Effect of a Single Bout of Intermittent versus Continuous Walking on Perceptions of Fatigue in People with Multiple Sclerosis.

Authors:  Herb Karpatkin; Adam Rzetelny
Journal:  Int J MS Care       Date:  2012

Review 3.  Relationship between perceived fatigue and performance fatigability in people with multiple sclerosis: A systematic review and meta-analysis.

Authors:  Bryan D Loy; Ruby L Taylor; Brett W Fling; Fay B Horak
Journal:  J Psychosom Res       Date:  2017-06-27       Impact factor: 3.006

4.  Fatigue in multiple sclerosis persists over time: a longitudinal study.

Authors:  N Téllez; J Río; M Tintoré; C Nos; I Galán; X Montalban
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

5.  Validation of the Fatigue Impact Scale in Hungarian patients with multiple sclerosis.

Authors:  Erika Losonczi; Krisztina Bencsik; Cecília Rajda; Gyula Lencsés; Margit Török; László Vécsei
Journal:  Qual Life Res       Date:  2010-09-24       Impact factor: 4.147

Review 6.  [Therapy of fatigue in multiple sclerosis : A treatment algorithm].

Authors:  C Veauthier; F Paul
Journal:  Nervenarzt       Date:  2016-12       Impact factor: 1.214

7.  Associations Between Fatigue and Disability, Functional Mobility, Depression, and Quality of Life in People with Multiple Sclerosis.

Authors:  Hina Garg; Steffani Bush; Eduard Gappmaier
Journal:  Int J MS Care       Date:  2016 Mar-Apr

Review 8.  Altered neuronal-glial signaling in glutamatergic transmission as a unifying mechanism in chronic pain and mental fatigue.

Authors:  Elisabeth Hansson; Lars Rönnbäck
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

9.  Physical dimension of fatigue correlated with disability change over time in patients with multiple sclerosis.

Authors:  Marc Debouverie; Sophie Pittion-Vouyovitch; Hélène Brissart; Francis Guillemin
Journal:  J Neurol       Date:  2008-01-29       Impact factor: 4.849

10.  Sleep disorders are long-term sequelae of both bacterial and viral meningitis.

Authors:  H Schmidt; S Cohrs; T Heinemann; C Goerdt; M Djukic; B Heimann; C-W Wallesch; R Nau
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.